Cannara Biotech Inc.
Sign in to search companies, open filing PDFs, fetch uncached SEDAR+ documents, and use the
full company research view.
Transactions 2026-05-06 M&A
Cannara Completes Acquisition of Medican Organic Inc. and Appoints Nicholas Sosiak as Chief Operating Officer
News release - English.pdf
Results 2026-04-14
Interim financial statements/report – English.pdf
Results 2026-04-14
Interim MD&A - English.pdf
Results 2026-04-14
Cannara Reports Q2 Fiscal 2026 Results with Continued Profitability, Strong Operating Cash Flow and #1 Retail Market Share in Québec
News release - English.pdf
Results 2026-04-07
Cannara to Announce Fiscal Q2 2026 Financial Results on April 14, 2026
News release - English.pdf
News 2026-03-12
Notice.pdf
News 2026-03-09
Notice.pdf
Ownership 2026-03-09
Sherman, Brian bought +$973
Insider trading – 2026-03-09
1 insider · +$973 net
Ownership 2026-03-06
Olds, Donald John bought +$203k
Insider trading – 2026-03-06
1 insider · +$203k net
Ownership 2026-02-13
Krivorot, Zohar sold +$700k
Insider trading – 2026-02-13
1 insider · −$700k net
News 2026-02-06
Report of exempt distribution (45-106F1).pdf
Transactions 2026-02-05 Financing
Cannara Biotech Inc. Announces Completion of Strategic, Non-Brokered Private Placement and Secondary Share Sale
Material change report - English.pdf
Transactions 2026-02-04 Financing
Cannara Announces Strategic C$6.3 Million Non-Brokered Private Placement Priced at C$2.10 per Common Share
News release - English.pdf
Results 2026-01-26 Financials
Interim MD&A - English.pdf
Results 2026-01-26 Financials
Interim financial statements/report – English.pdf
Results 2026-01-26
Cannara Reports Q1 Fiscal 2026 Results, Delivers New Record Financial Results, Extends Market Share Gains and Advances Disciplined Expansion Strategy
News release - English.pdf
Results 2026-01-02
Cannara Achieves #1 Market Share Position in Québec as of December 2025 and Provides Update on Québec Vape Category Launch
News release - English.pdf
News 2025-12-21
Other.pdf
Results 2025-11-24 Financials
Annual information form - English.pdf
Results 2025-11-24 Financials
Annual MD&A - English.pdf
Results 2025-11-24 Financials
Audited annual financial statements – English.pdf
Results 2025-11-24
Cannara Biotech Delivers Record Fiscal 2025 Revenue and Profitability, Achieves First Year of Positive Retained Earnings
News release - English.pdf
Results 2025-11-17
Cannara Biotech Inc. to Announce Fiscal Q4 2025 and Fiscal Year 2025 Financial Results on November 24, 2025 and Provides Board Update
News release - English.pdf
News 2025-10-07
News release - English.pdf
News 2025-10-02
Material change report - English.pdf
News 2025-10-02
News release - English.pdf
News 2025-09-01
News release - English.pdf
News 2025-08-27
Material change report - English.pdf
Transactions 2025-08-27
Material contracts - Credit agreements.pdf
News 2025-08-21
News release - English.pdf
News 2025-08-14
News release - English.pdf
News 2025-07-28
News release - English.pdf
Results 2025-07-28 Financials
Interim financial statements/report – English.pdf
Results 2025-07-28 Financials
Interim MD&A - English.pdf
News 2025-07-24
News release - English.pdf
News 2025-07-21
News release - English.pdf
News 2025-06-19
News release - English.pdf
News 2025-06-18
News release - English.pdf
Ownership 2025-05-07
Olymbec Investments Inc. bought +$350k
Insider trading – 2025-05-07
1 insider · +$350k net
Ownership 2025-05-06
Olymbec Investments Inc. bought +$152k
Insider trading – 2025-05-06
1 insider · +$152k net
Ownership 2024-12-19
Sosiak, Nicholas bought +$8k
Insider trading – 2024-12-19
1 insider · +$8k net
Ownership 2024-12-02
2 insiders · +$41k net
Insider trading – 2024-12-02
2 insiders · +$41k net
Ownership 2024-08-21
2 insiders · +$184k net
Insider trading – 2024-08-21
2 insiders · +$184k net
Ownership 2024-08-16
2 insiders · +$87k net
Insider trading – 2024-08-16
2 insiders · +$87k net
Ownership 2024-07-29
2 insiders · +$60k net
Insider trading – 2024-07-29
2 insiders · +$60k net
Ownership 2024-07-27
Sosiak, Nicholas bought +$2k
Insider trading – 2024-07-27
1 insider · +$2k net